Phillip Ravencroft
Papers
2
Total Citations
346
H-Index
2
About
Phillip Ravencroft is a leading urologic oncologist whose work is reshaping the surgical management of bladder cancer. His research centers on the comparative effectiveness and health economics of robotic surgery, specifically focusing on whether robot-assisted radical cystectomy with intracorporeal urinary diversion (iRARC) offers tangible advantages over traditional open surgery. Ravencroft’s most influential contribution is a landmark 2022 study, cited over 320 times, which rigorously compared iRARC to open radical cystectomy, providing critical evidence on 90-day morbidity and mortality. This work directly addressed a key clinical debate, demonstrating that while robotic approaches are increasingly popular, their recovery benefits require careful scrutiny. He further advanced the field with a 2023 cost-effectiveness analysis, a vital piece of research that evaluates the economic value of robotic surgery for payers and healthcare systems. By combining clinical outcomes with economic modeling, Ravencroft provides a comprehensive framework for decision-making in bladder cancer care. His work is essential reading for surgeons and policymakers navigating the high-stakes trade-offs between innovation, patient recovery, and healthcare costs.
Research Focus
Key Achievements
Top Papers
- 1
- 2